Cann Group Limited (CAN.AX)
Cann Group Limited operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Mildura, VIC, AU. The stock last traded at $0.00, down 14.29% on the session, giving a market capitalisation of $2.1M. Its beta of 0.05 implies it has historically moved less than the broad market.
Cann Group Limited, established in Port Melbourne, Australia, in 2014, specializes in the comprehensive lifecycle of medicinal cannabis. This includes genetic development, cultivation, manufacturing, clinical assessment, and the distribution of therapeutic cannabis products. The company supplies these products for use within Australia and also exports them to international markets, operating under specific licenses that permit research and the cultivation of cannabis for human medicinal and scientific purposes.
Cann Group Limited is most often compared with the following Healthcare names: